Nov 21 (Reuters) - Medicenna Therapeutics Corp MDNA.TO :
* MEDICENNA THERAPEUTICS - NEW POSITIVE RESULTS ON DRUG DISTRIBUTION FROM PHASE 2B CLINICAL TRIAL OF MDNA55 FOR TREATMENT OF RECURRENT GLIOBLASTOMA
* MEDICENNA THERAPEUTICS CORP - MDNA55-05 STUDY SHOWED NEARLY 50% COVERAGE OF TUMOR, WITH SOME PATIENTS ACHIEVING OVER 90% COVERAGE OF TARGET VOLUME